Search

everythinglearnresearchcommunity

for

Search:↓

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

A boronic acid copolymer quickly forms cell clusters, useful for tissue and tumor modeling.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

The new fluoroquinolone effectively fights certain bacteria.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Targeting the Smoothened receptor shows promise for treating certain cancers.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

CMC2.24 and CMC2.23 reduce melanin safely and effectively.

Using ultrasound may make cisplatin more effective against cervical cancer in mice.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

A method was found to select hair follicle stem cells, and beta-catenin helps them grow and change.

NFATc1 is crucial for keeping hair follicle stem cells inactive.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

New cytokine-targeted therapies show promise for treating alopecia areata.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Cubosomes enhance antimicrobial peptide stability and effectiveness.

A new compound shows promise as a topical treatment for hair loss.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

NFATc1 controls hair stem cell activity, affecting hair growth and could be a target for hair loss treatments.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.